HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Michael P Lisanti Selected Research

Cyclin D1

4/2015Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.
1/2014Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
1/2014CAPER, a novel regulator of human breast cancer progression.
9/2013Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
9/2012Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
8/2009Altered expression of DACH1 and cyclin D1 in endometrial cancer.
7/2009Chagas disease, adipose tissue and the metabolic syndrome.
6/2009A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
9/2008ErbB2 induces Notch1 activity and function in breast cancer cells.
3/2008Inhibition of cyclin D1 gene transcription by Brg-1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Michael P Lisanti Research Topics

Disease

149Neoplasms (Cancer)
12/2015 - 03/2002
83Breast Neoplasms (Breast Cancer)
10/2015 - 10/2002
38Neoplasm Metastasis (Metastasis)
12/2015 - 10/2004
18Prostatic Neoplasms (Prostate Cancer)
05/2015 - 03/2005
15Inflammation
10/2015 - 06/2005
13Infection
03/2015 - 05/2003
10Atherosclerosis
01/2015 - 10/2002
10Anoxia (Hypoxia)
09/2012 - 04/2010
10Hyperplasia
11/2006 - 10/2002
7Cardiomyopathies (Cardiomyopathy)
04/2013 - 10/2002
6Carcinoma (Carcinomatosis)
05/2014 - 07/2003
6Muscular Dystrophies (Muscular Dystrophy)
04/2010 - 01/2002
5Fibrosis (Cirrhosis)
07/2013 - 11/2003
5Melanoma (Melanoma, Malignant)
05/2012 - 06/2009
4Adenocarcinoma
04/2015 - 11/2006
4Starvation
11/2012 - 08/2011
4Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
04/2010 - 10/2003
4Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
02/2010 - 01/2002
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2015 - 10/2008
3Hypertrophy
05/2013 - 08/2008
3Chagas Disease (American Trypanosomiasis)
03/2013 - 04/2011
3Insulin Resistance
02/2013 - 07/2003
3Multiple Myeloma
01/2013 - 05/2007
3Myocardial Infarction
04/2012 - 09/2004
3Systemic Scleroderma (Systemic Sclerosis)
07/2011 - 09/2008
3Noninfiltrating Intraductal Carcinoma (DCIS)
06/2010 - 04/2009
3Obesity
05/2010 - 03/2002
3Distal Myopathies (Distal Muscular Dystrophy)
02/2010 - 11/2003
3Cardiomegaly (Heart Hypertrophy)
08/2008 - 06/2002
3Vascular Diseases (Vascular Disease)
01/2007 - 07/2003
2Tics (Tic)
06/2015 - 03/2015
2Aneuploidy (Aneuploid)
04/2015 - 08/2010
2Communicable Diseases (Infectious Diseases)
03/2015 - 08/2013

Drug/Important Bio-Agent (IBA)

80Caveolin 1IBA
04/2014 - 03/2002
38Carbon MonoxideIBA
10/2015 - 10/2008
28Lactic AcidFDA LinkGeneric
04/2014 - 12/2009
22Cyclin D1IBA
04/2015 - 05/2003
16Proteins (Proteins, Gene)IBA
10/2015 - 08/2006
16Phosphotransferases (Kinase)IBA
04/2015 - 02/2003
13Biological Markers (Surrogate Marker)IBA
10/2015 - 06/2002
13KetonesIBA
09/2013 - 09/2010
12Caveolin 3IBA
01/2015 - 01/2002
11Glutamine (L-Glutamine)FDA Link
04/2014 - 09/2010
11TamoxifenFDA LinkGeneric
12/2011 - 08/2008
10AntioxidantsIBA
12/2015 - 01/2011
10Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2012 - 08/2011
9Estrogens (Estrogen)FDA Link
09/2015 - 11/2006
9CyclinsIBA
01/2014 - 08/2005
9Metformin (Glucophage)FDA LinkGeneric
05/2013 - 08/2010
9CholesterolIBA
01/2013 - 10/2002
8Transcription Factors (Transcription Factor)IBA
09/2015 - 05/2003
8CaveolinsIBA
03/2011 - 03/2002
7Ketone BodiesIBA
04/2014 - 04/2012
7Glucose (Dextrose)FDA LinkGeneric
03/2013 - 06/2005
6DNA (Deoxyribonucleic Acid)IBA
06/2015 - 05/2003
6Adenosine Triphosphate (ATP)IBA
01/2013 - 12/2009
5EnzymesIBA
10/2015 - 12/2009
5Lipoproteins (Lipoprotein)IBA
12/2014 - 01/2004
5Oxidants (Oxidizing Agents)IBA
04/2014 - 08/2010
5AntibodiesIBA
12/2012 - 06/2009
4Doxycycline (Vibramycin)FDA LinkGeneric
06/2015 - 01/2015
4Fatty Acids (Saturated Fatty Acids)IBA
04/2014 - 01/2012
4Insulin (Novolin)FDA Link
03/2013 - 06/2005
4Cysteine (L-Cysteine)FDA Link
01/2013 - 08/2010
4DystrophinIBA
01/2013 - 10/2003
4Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2011 - 05/2003
4Rippling muscle diseaseIBA
02/2010 - 11/2003
3Interleukin-6 (Interleukin 6)IBA
05/2015 - 07/2012
3Interleukin-8 (Interleukin 8)IBA
05/2015 - 05/2008
3InterferonsIBA
05/2015 - 07/2012
3Phenobarbital (Luminal)FDA Link
01/2015 - 07/2004
3Estrogen Receptor alphaIBA
05/2014 - 06/2006
3Amino AcidsFDA Link
04/2014 - 09/2010
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2014 - 10/2006
3CollagenIBA
07/2013 - 05/2005
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2013 - 02/2006
3bortezomib (Velcade)FDA Link
01/2013 - 05/2007
3MicroRNAs (MicroRNA)IBA
12/2012 - 03/2010
3Chloroquine (Aralen)FDA LinkGeneric
12/2012 - 06/2010
3RNA (Ribonucleic Acid)IBA
11/2012 - 06/2002
3LigandsIBA
08/2012 - 11/2009
3Protein Kinases (Protein Kinase)IBA
03/2012 - 09/2004
3beta CateninIBA
11/2011 - 09/2003
3CatalaseIBA
08/2011 - 01/2011
3Dietary Fats (Ghee)IBA
12/2010 - 04/2005
3Pyruvic Acid (Pyruvate)IBA
09/2010 - 12/2009
3PPAR gammaIBA
11/2009 - 09/2008
3Transforming Growth Factor beta (TGF-beta)IBA
11/2008 - 12/2003
3Fatty Acid Synthetase Complex (Fatty Acid Synthase)IBA
10/2008 - 04/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2015 - 09/2010
2XCT790IBA
09/2015 - 06/2015
2Anti-Bacterial Agents (Antibiotics)IBA
03/2015 - 08/2013
2ProteomeIBA
03/2015 - 06/2013
2Methionine (L-Methionine)FDA Link
03/2015 - 03/2008

Therapy/Procedure

19Heterologous Transplantation (Xenotransplantation)
10/2015 - 05/2010
9Drug Therapy (Chemotherapy)
10/2015 - 09/2005
5Therapeutics
04/2015 - 06/2010
4Individualized Medicine
10/2015 - 04/2011
3Lasers (Laser)
10/2015 - 06/2006
2Caloric Restriction
03/2015 - 06/2013